Key result
Endothelin-1 regulates coronary circulation via ETA-mediated constriction and ETB-mediated dilation, suggesting ET receptor blockade may improve the match between metabolic demand and perfusion.
Why the study?
Does ET receptor blockade improve the match between cardiac metabolic demand and coronary perfusion in the context of elevated ET-1 levels?
Does ET receptor blockade improve the match between cardiac metabolic demand and coronary perfusion in the context of elevated ET-1 levels?
This review highlights the role of ET-1 in coronary vasoconstriction via ETA receptors and suggests ET receptor blockade as a potential mechanism to improve coronary perfusion in conditions like heart failure.
Answers are grounded in this paper and cite their sources.
ET-1 coronary effects may support ETA-targeted exploration in HF; leaves open clinical efficacy pending prospective trials.
Given that circulating ET levels in heart failure, in particular, may reach physiological threshold for coronary constrictor responses, the primary objective of the present review is to consider coronary vessels as an important target for circulating and locally produced endothelin(s). In healthy vessels, ET-1 causes biphasic coronary responses characterized by a transient dilation of large and small arteries followed by a sustained constriction. ETB receptors are pivotal in the early dilation of resistance vessels, whereas dilation of conductance vessels may be a secondary phenomenon triggered by flow increases. Exogenous ET-1 causes coronary constriction almost exclusively through ETA receptor activation. Human and canine large epicardial coronary vessels display significant baseline ET-1 dependent tone in vitro and in vivo, an ETA-dependent process. In contrast, ETB receptors located on smooth muscle cells are apparently less important for producing constrictor responses. NO production may serve as an important counter-regulatory mechanism to limit ET-dependent effects on coronary vessels. Conversely, in a dysfunctional endothelium, the loss of NO may augment ET-1 production and activity. By lifting the ET-dependent burden from coronary vessels, ET receptor blockade should help to ensure a closer match between cardiac metabolic demand and coronary perfusion.
No takes yet. Share an insight, caveat, or question.
Lavallée et al. (2003) conducted a review in Heart failure. Endothelin-1 (ET-1) was evaluated. Endothelin-1 regulates coronary circulation via ETA-mediated constriction and ETB-mediated dilation, suggesting ET receptor blockade may improve the match between metabolic demand and perfusion.
Synapse has enriched 10 related papers. Consider them for comparative context: